174 related articles for article (PubMed ID: 34169422)
41. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
42. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
[TBL] [Abstract][Full Text] [Related]
43. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
Zheng J; Sun X; Wang W; Lu S
Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
[TBL] [Abstract][Full Text] [Related]
45. The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer.
Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; He Q; Yu W
Gene; 2020 Sep; 754():144851. PubMed ID: 32525044
[TBL] [Abstract][Full Text] [Related]
46. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
[TBL] [Abstract][Full Text] [Related]
47. RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
Kim BR; Kang MH; Kim JL; Na YJ; Park SH; Lee SI; Kang S; Joung SY; Lee SY; Lee DH; Min BW; Oh SC
Oncol Rep; 2016 Nov; 36(5):2601-2608. PubMed ID: 27633042
[TBL] [Abstract][Full Text] [Related]
48. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
49. Correlation of Delta-like ligand 4 (DLL4) with VEGF and HIF-1α expression in human glioma.
Li Z; Wang J; Gong L; Wen Z; Xu C; Huang X
Asian Pac J Cancer Prev; 2011; 12(1):215-8. PubMed ID: 21517260
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer.
Qiu Y; Zheng H; Sun LH; Peng K; Xiao WD; Yang H
World J Gastroenterol; 2015 Dec; 21(48):13447-56. PubMed ID: 26730155
[TBL] [Abstract][Full Text] [Related]
51. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
[TBL] [Abstract][Full Text] [Related]
53. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.
Zhang J; Zhu L; Fang J; Ge Z; Li X
J Exp Clin Cancer Res; 2016 Feb; 35():29. PubMed ID: 26856989
[TBL] [Abstract][Full Text] [Related]
54. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
55. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
Oh SY; Kwon HC; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim CO; Kim SJ; Jeong JS; Kim HJ
BMC Cancer; 2008 May; 8():123. PubMed ID: 18452596
[TBL] [Abstract][Full Text] [Related]
57. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.
Rajaganeshan R; Prasad R; Guillou PJ; Scott N; Poston G; Jayne DG
Eur J Surg Oncol; 2009 Dec; 35(12):1286-94. PubMed ID: 19540709
[TBL] [Abstract][Full Text] [Related]
58. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer.
Kwon HC; Kim SH; Oh SY; Lee S; Kwon KA; Lee JH; Choi HJ; Park KJ; Lee HS; Roh MS; Kim HJ
Cancer Sci; 2010 Jun; 101(6):1557-61. PubMed ID: 20398057
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
